Janine Rupp

Janine Rupp

Auto-generated profile, based on publicly available information

Janine Rupp

Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz , 8036 Graz

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JRJanine Rupp
Janine Rupp
BDBarbara Dreo
Barbara Dreo
KGKatharina Gütl
Katharina Gütl
JFJohannes Fessler
Johannes Fessler
AMAdrian Moser
Adrian Moser
MSMartin Helmut Stradner
Martin Helmut Stradner
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become pandemic. Cytokine release syndrome occurring in a minority of SARS-CoV-2 infections is associated with severe disease and high mortality. We profiled the composition, activation, and proliferation of T cells in 20 patients with severe or critical COVID-19 and 40 matched healthy controls by flow cytometry. Unsupervised hierarchical cluster analysis based on 18 T cell subsets resulted in separation of healthy controls and COVID-19 patients. Compared to healthy controls, patients suffering from severe and critical COVID-19 had increased frequencies of activated and proliferating CD38+Ki67+ CD4+ and CD8+ T cells, suggesting active antiviral T cell defense. Frequencies of CD38+Ki67+ Th1 and CD4+ cells correlated negatively with plasma IL-6. Thus, our data suggest that patients suffering from COVID-19 have a distinct T cell composition that is potentially modulated by IL-6. Key Points Distribution of T cell subsets is altered in COVID-19 compared to healthy subjects. Cytotoxic and Th1 cells are activated and proliferating in COVID-19. Activated and proliferating Th1 cells negatively correlate with plasma IL-6.